Case | Treatment | Primary Site | Specimen Site | EGFRvIII by RT-PCR | EGFRvIII Fold Changes | HPV DNA by Linear Array | P16 IHC | MET score by IHC | EGFR FISH |
---|---|---|---|---|---|---|---|---|---|
1 | Erlotinib | hypopharynx | Untreated primary | + | 11.33 | - | - | High | Low polysomy |
2 | Erlotinib | oral cavity | Untreated primary | + | 7.01 | - | - | High | Disomy |
3 | Erlotinib | larynx | Untreated primary | + | 61.77 | - | - | Low | Low polysomy |
4 | Erlotinib | larynx | Local recurrence | + | 26.64 | - | - | Low | High polysomy |
5 | Erlotinib | neck mass unknown primary | Untreated lymph node | + | 60.04 | 33 + | + | High | Low trisomy |
6 | Erlotinib | oral cavity | Untreated lymph node | + | 218.49 | - | - | High | Amplification |
7 | Erlotinib | oropharynx | Unknown primary | + | 15.66 | 16 + | + | High | Low trisomy |
8 | Erlotinib | oral cavity | Local recurrence | + | 8.94 | - | - | High | Low polysomy |
9 | Erlotinib + Cisplatin | neck mass unknown primary | Untreated lymph node | + | 127.84 | 16+ | NE | NE | Low trisomy |
10 | Erlotinib + Cisplatin | larynx | Node recurrence | + | 576.36 | 16+ | + | High | Disomy |
11 | Erlotinib + Cisplatin | larynx | Untreated primary | + | 8.26 | - | - | Low | Failed |
12 | Erlotinib + Cisplatin | larynx | Untreated primary | + | 17.38 | - | - | High | Low polysomy |
13 | Erlotinib + Cisplatin | oropharynx | Untreated primary | + | 14.28 | 16+ | + | High | Disomy |
14 | Erlotinib + Cisplatin | oral cavity | Untreated primary | + | 69.68 | - | NE | NE | Low polysomy |
15 | Erlotinib + Cisplatin | oral cavity | Untreated primary | + | 11.11 | 53+, 58+, 6+, 52+ | - | High | Low polysomy |
16 | Sorafenib | oropharynx | Untreated primary | + | 7.71 | 16 + | + | Low | Low polysomy |
17 | Sorafenib | oropharynx | Untreated primary | + | 7.93 | 16 + | + | Low | Low trisomy |
18 | Ispinesib | neck mass unknown primary | Untreated lymph node | + | 4.12 | 16+, 53+, 51 + | + | High | High polysomy |
19 | Ispinesib | oropharynx | Untreated primary | + | 15.61 | 16+, 53+, 33+, 51+, 58 + | - | High | High polysomy |
20 | Ispinesib | larynx | Untreated primary | + | 218.26 | - | - | High | Disomy |
21 | Ispinesib | oropharynx | Local recurrence | + | 29.25 | 16+, 53+, 51+ | + | Low | Disomy |
22 | Ispinesib | hypopharynx | Local recurrence | + | 9.31 | 16+, 53+, 58+, 52+ | - | High | Low polysomy |